BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
Number Citing Articles
1 [DOI: 10.1101/2020.03.20.000794] [Cited by in Crossref: 20] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
2 Liu G, Carter B, Bricken T, Jain S, Viard M, Carrington M, Gifford DK. Robust computational design and evaluation of peptide vaccines for cellular immunity with application to SARS-CoV-2. bioRxiv 2020:2020. [PMID: 32511351 DOI: 10.1101/2020.05.16.088989] [Cited by in Crossref: 5] [Article Influence: 2.5] [Reference Citation Analysis]
3 [DOI: 10.1101/2020.02.28.970343] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
4 Baviskar T, Raut D, Bhatt LK. Deciphering Vaccines for COVID-19: where do we stand today? Immunopharmacol Immunotoxicol 2021;43:8-21. [PMID: 33054486 DOI: 10.1080/08923973.2020.1837867] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
5 Lozano Jiménez YY, Sánchez Mora RM, Giraldo Quintero SE. Potenciales estrategias terapéuticas basadas en péptidos para mitigar la infección por SARS-CoV-2. nova 2020;18:61-6. [DOI: 10.22490/24629448.4187] [Reference Citation Analysis]